MetLife, Inc.
NYSEMET saw short interest surge 27% last week, reaching 14.12 million shares as of March 31. The jump marks the latest leg in a broader trend that has pushed short positions up 29.5% over the past month. Days to cover climbed to 3.67, up from 2.96 two weeks prior. This measure calculates how many trading days it would take short sellers to close their positions at recent volume levels. The increase reflects both growing short interest and relatively thin trading. Cost to borrow remains modest at 0.47%, though it has ticked up 31% from month-ago levels. Utilization sits at just 0.43%, well below the 52-week high of 2.76%. Plenty of shares remain available to borrow. MetLife shares closed at $77.48 on April 21, up 1.9% for the week and 13% for the month. The stock has rallied even as short sellers have increased their positions. Put/call ratio stands at 1.59, below its 20-day average of 1.63. Options traders appear slightly less bearish than recent norms, with the ratio sitting in the middle of its 52-week range. The insurer reports earnings April 30. Previous quarters have seen estimates announced in October, January, and February. MetLife operates in the life and health insurance sector. Short interest relative to float is not available due to missing float data. The current short position represents roughly 0.3% of the company's outstanding shares based on typical institutional ownership patterns for large-cap insurers. This is not financial advice. ORTEX data may contain errors.
Short Sellers Ramp Up MetLife Bets
MET saw short interest surge 27% last week, reaching 14.12 million shares as of March 31. The jump marks the latest leg in a broader trend that has pushed short positions up 29.5% over the past month. Days to cover climbed to 3.67, up from 2.96 two weeks prior. This measure calculates how many trading days it would take short sellers to close their positions at recent volume levels. The increase reflects both growing short interest and relatively thin trading. Cost to borrow remains modest at 0.47%, though it has ticked up 31% from month-ago levels. Utilization sits at just 0.43%, well below the 52-week high of 2.76%. Plenty of shares remain available to borrow. MetLife shares closed at $77.48 on April 21, up 1.9% for the week and 13% for the month. The stock has rallied even as short sellers have increased their positions. Put/call ratio stands at 1.59, below its 20-day average of 1.63. Options traders appear slightly less bearish than recent norms, with the ratio sitting in the middle of its 52-week range. The insurer reports earnings April 30. Previous quarters have seen estimates announced in October, January, and February. MetLife operates in the life and health insurance sector. Short interest relative to float is not available due to missing float data. The current short position represents roughly 0.3% of the company's outstanding shares based on typical institutional ownership patterns for large-cap insurers. This is not financial advice. ORTEX data may contain errors.
Snapshot as of 7 May 2026
MetLife heads into its first-quarter results reveal — posted after the close on May 6 — with the stock having already climbed 13% in a month, shorts retreating, and the Street lined up bullishly despite a wave of…
MetLife reports first-quarter 2026 results on May 6 with short sellers notably pulling back even as the stock posts its strongest month in recent memory. The clearest signal heading into the print is that bears have…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for MET — free to start on ORTEX.
Sign up for free →Open MET on ORTEX